Starling Medical, Inc. — Form D/A
Starling Medical, Inc. of HOUSTON, TX, a company, filed a Form D amendment with the SEC on 2024-12-09. The offering totals $8.9M, of which $8.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-12-09
- Form: D/A
- Accession: 0001935581-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.9M
- Amount sold: $8.9M
- Investors: 40
- Date of first sale: 2024-09-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-524343
Issuer
- Name: Starling Medical, Inc.
- CIK: 0002031505
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 2450 Holcombe Boulevard, HOUSTON, TX, 77021
- Phone: 888-599-8927
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Shana Andrew Barghouti | Director | Houston, TX |
| William Andrew Hendricks | Director | Houston, TX |
| Hannah Andrew McKenney | Director | Houston, TX |
| Kunj Andrew Sheth | Director | Houston, TX |
| Hannah Andrew McKenney | Executive Officer | Houston, TX |
| William Andrew Hagaman | Director | Houston, TX |
Other filings by this issuer (2)
More